Aditya Bagrodia

Then you have research assistants that support these trials for three years. You have kind of all this stuff, this clutter, if you will, baked in, which makes it onerous to the research staff. The cost can become prohibitive immediately. And you end up saying, is it worth spending $2 million to try to answer this question? Not only is it worth, can I get somebody to pay that?

Then you have research assistants that support these trials for three years. You have kind of all this stuff, this clutter, if you will, baked in, which makes it onerous to the research staff. The cost can become prohibitive immediately. And you end up saying, is it worth spending $2 million to try to answer this question? Not only is it worth, can I get somebody to pay that?

which is another tricky one. But it's almost like if we can just use a little bit of common sense, there are checks and balances to make sure this doesn't go rogue, I suppose. And it sounds like there's a kind of an oversight committee. You can answer questions that are worth answering without making it so intensive, laborious, cluttered, as you say, so that it never gets off the ground.

which is another tricky one. But it's almost like if we can just use a little bit of common sense, there are checks and balances to make sure this doesn't go rogue, I suppose. And it sounds like there's a kind of an oversight committee. You can answer questions that are worth answering without making it so intensive, laborious, cluttered, as you say, so that it never gets off the ground.

which is another tricky one. But it's almost like if we can just use a little bit of common sense, there are checks and balances to make sure this doesn't go rogue, I suppose. And it sounds like there's a kind of an oversight committee. You can answer questions that are worth answering without making it so intensive, laborious, cluttered, as you say, so that it never gets off the ground.

Yeah. I mean, it's one of those things that's obvious and it's not. I mean, this is separate, but perhaps related. At many institutions now, a blanket IRB for retrospective studies that pose zero risk to a patient are disallowed. Or biospecimen collection protocols may be challenging to get through. MTAs, DTAs between institutions can be a little bit complicated. And

Yeah. I mean, it's one of those things that's obvious and it's not. I mean, this is separate, but perhaps related. At many institutions now, a blanket IRB for retrospective studies that pose zero risk to a patient are disallowed. Or biospecimen collection protocols may be challenging to get through. MTAs, DTAs between institutions can be a little bit complicated. And

Yeah. I mean, it's one of those things that's obvious and it's not. I mean, this is separate, but perhaps related. At many institutions now, a blanket IRB for retrospective studies that pose zero risk to a patient are disallowed. Or biospecimen collection protocols may be challenging to get through. MTAs, DTAs between institutions can be a little bit complicated. And

I guess, you know, just reflecting back in America, I think a few bad apples can really screw it up for everybody. You know, a perfect example is, in my opinion, when you go through the airport, you can't take something more than three ounces. You got to take your shoes off because somebody once upon a time did some stupid stuff with shoes and a small bottle of whatever. I mean, is that it?

I guess, you know, just reflecting back in America, I think a few bad apples can really screw it up for everybody. You know, a perfect example is, in my opinion, when you go through the airport, you can't take something more than three ounces. You got to take your shoes off because somebody once upon a time did some stupid stuff with shoes and a small bottle of whatever. I mean, is that it?

I guess, you know, just reflecting back in America, I think a few bad apples can really screw it up for everybody. You know, a perfect example is, in my opinion, when you go through the airport, you can't take something more than three ounces. You got to take your shoes off because somebody once upon a time did some stupid stuff with shoes and a small bottle of whatever. I mean, is that it?

Are we kind of handcuffed in so many ways because some of these things have gone awry when providers are given latitude?

Are we kind of handcuffed in so many ways because some of these things have gone awry when providers are given latitude?

Are we kind of handcuffed in so many ways because some of these things have gone awry when providers are given latitude?

I mean, it sounds simple and it's genius. You saw me smiling. For our listeners, they obviously couldn't see me smiling because it is tough, right? When you're approaching somebody for a trial and you're excited about the new and you're trying to couch that in a balanced type of discussion, it's challenging. Yeah. Yeah, I love that.

I mean, it sounds simple and it's genius. You saw me smiling. For our listeners, they obviously couldn't see me smiling because it is tough, right? When you're approaching somebody for a trial and you're excited about the new and you're trying to couch that in a balanced type of discussion, it's challenging. Yeah. Yeah, I love that.

I mean, it sounds simple and it's genius. You saw me smiling. For our listeners, they obviously couldn't see me smiling because it is tough, right? When you're approaching somebody for a trial and you're excited about the new and you're trying to couch that in a balanced type of discussion, it's challenging. Yeah. Yeah, I love that.

So, you know, just to kind of maybe dig into this a bit further, the consent is actually taking place at that first introduction of the concept that we may reach out to you about interventions to improve the biopsy experience or the systo experience. And then... Your recording outcomes, which seems to be a critical common theme here. Then you intervene.

So, you know, just to kind of maybe dig into this a bit further, the consent is actually taking place at that first introduction of the concept that we may reach out to you about interventions to improve the biopsy experience or the systo experience. And then... Your recording outcomes, which seems to be a critical common theme here. Then you intervene.

So, you know, just to kind of maybe dig into this a bit further, the consent is actually taking place at that first introduction of the concept that we may reach out to you about interventions to improve the biopsy experience or the systo experience. And then... Your recording outcomes, which seems to be a critical common theme here. Then you intervene.